Related Experiment Video
Updated: Sep 26, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
UBE2L6 drives ulcerative colitis progression by promoting BIRC2 degradation and activating non-canonical NF-κB
Zhiyi Cheng1, Chao Yu2, Guiyuan Liu1
1Department of General Surgery, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taihu Road No. 366, Taizhou, 225304, China.
Background:
Post-translational modifications (PTMs) have been increasingly recognized as important regulators of ulcerative colitis (UC) progression. However, the specific PTM type and key enzyme driving UC remain largely undefined.
Methods:
Genes related to 21 PTM types were intersected with differentially expressed genes (DEGs) in UC and screened using 113 machine learning algorithms. Functional validation was performed in lipopolysaccharide (LPS) stimulated NCM460 and HT29 cells. Immunoprecipitation-mass spectrometry (IP-MS) combined with data-independent acquisition (DIA) proteomics was used to identify downstream targets and pathways.
Results:
UBE2L6 was identified as a key PTM-related gene in UC. In LPS stimulated intestinal epithelial cells, UBE2L6 downregulation was found to markedly attenuate inflammatory responses and barrier dysfunction. BIRC2 was identified as a downstream target of UBE2L6, and the non-canonical NF-κB pathway was determined to be the principal signalling axis involved. Mechanistically, UBE2L6 was shown to facilitate the transfer of K48 linked ubiquitin chains to BIRC2, thereby promoting BIRC2 autoubiquitination and degradation. Consequently, NIK degradation was impaired, leading to NIK accumulation, enhanced p100 processing to p52, and activation of non-canonical NF-κB signalling.
Conclusions:
UBE2L6 promotes UC progression through BIRC2 degradation-dependent activation of the non-canonical NF-κB pathway and may serve as a potential therapeutic target in UC.
Related Concept Videos
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
